Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Testosterone helps human pancreatic cells increase insulin release.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

Topical vitamin D is effective in treating vitiligo with few side effects.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

People with alopecia areata often have thyroid autoimmunity.

Syphilis is becoming more common and remains a major health problem due to challenges in prevention and treatment.

Pantethine may boost the immune system's ability to fight sarcoma.

The document concludes that misdiagnosis in skin conditions is common, certain treatments can cause allergic reactions, and some skin symptoms are linked to leukemia, especially in certain Japanese regions.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.